-
1
-
-
84866122688
-
Autophagy modulation as a potential therapeutic target for diverse diseases
-
Rubinsztein DC, Codogno P and Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2013; 11(9):709-730.
-
(2013)
Nat Rev Drug Discov.
, vol.11
, Issue.9
, pp. 709-730
-
-
Rubinsztein, D.C.1
Codogno, P.2
Levine, B.3
-
2
-
-
77956404377
-
Eaten alive: a history of macroautophagy
-
Yang Z and Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010; 12(9):814-822.
-
(2010)
Nat Cell Biol.
, vol.12
, Issue.9
, pp. 814-822
-
-
Yang, Z.1
Klionsky, D.J.2
-
3
-
-
78049486018
-
Autophagy in liver diseases
-
Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D and Moreau R. Autophagy in liver diseases. J Hepatol. 2010; 53(6):1123-1134.
-
(2010)
J Hepatol.
, vol.53
, Issue.6
, pp. 1123-1134
-
-
Rautou, P.E.1
Mansouri, A.2
Lebrec, D.3
Durand, F.4
Valla, D.5
Moreau, R.6
-
4
-
-
56449107131
-
Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma
-
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B and Fan J. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008; 68(22):9167-9175.
-
(2008)
Cancer Res.
, vol.68
, Issue.22
, pp. 9167-9175
-
-
Ding, Z.B.1
Shi, Y.H.2
Zhou, J.3
Qiu, S.J.4
Xu, Y.5
Dai, Z.6
Shi, G.M.7
Wang, X.Y.8
Ke, A.W.9
Wu, B.10
Fan, J.11
-
6
-
-
84873619831
-
MicroRNA: a third dimension in autophagy
-
Zhai H, Fesler A and Ju J. MicroRNA: a third dimension in autophagy. Cell Cycle. 2013; 12(2):246-250.
-
(2013)
Cell Cycle.
, vol.12
, Issue.2
, pp. 246-250
-
-
Zhai, H.1
Fesler, A.2
Ju, J.3
-
7
-
-
69449097865
-
Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells
-
Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, Liu CG and Yang JM. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy. 2009; 5(6):816-823.
-
(2009)
Autophagy.
, vol.5
, Issue.6
, pp. 816-823
-
-
Zhu, H.1
Wu, H.2
Liu, X.3
Li, B.4
Chen, Y.5
Ren, X.6
Liu, C.G.7
Yang, J.M.8
-
8
-
-
81255143302
-
microRNA-101 is a potent inhibitor of autophagy
-
Frankel LB, Wen J, Lees M, Hoyer-Hansen M, Farkas T, Krogh A, Jaattela M and Lund AH. microRNA-101 is a potent inhibitor of autophagy. The EMBO Journal. 2011; 30(22):4628-4641.
-
(2011)
The EMBO Journal.
, vol.30
, Issue.22
, pp. 4628-4641
-
-
Frankel, L.B.1
Wen, J.2
Lees, M.3
Hoyer-Hansen, M.4
Farkas, T.5
Krogh, A.6
Jaattela, M.7
Lund, A.H.8
-
9
-
-
84884211455
-
Inhibition of autophagy and tumor growth in colon cancer by miR-502
-
Zhai H, Song B, Xu X, Zhu W and Ju J. Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene. 2013; 32(12):1570-1579.
-
(2013)
Oncogene.
, vol.32
, Issue.12
, pp. 1570-1579
-
-
Zhai, H.1
Song, B.2
Xu, X.3
Zhu, W.4
Ju, J.5
-
10
-
-
79960670757
-
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3
-
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res. 2011; 9(7):824-833.
-
(2011)
Mol Cancer Res.
, vol.9
, Issue.7
, pp. 824-833
-
-
Li, X.1
Zhang, Y.2
Zhang, H.3
Liu, X.4
Gong, T.5
Li, M.6
Sun, L.7
Ji, G.8
Shi, Y.9
Han, Z.10
Han, S.11
Nie, Y.12
Chen, X.13
Zhao, Q.14
Ding, J.15
Wu, K.16
-
11
-
-
70649110008
-
MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia
-
Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J, Zhou H, Qu LH, Xu L and Chen YQ. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PloS one. 2009; 4(11):e7826.
-
(2009)
PloS one.
, vol.4
, Issue.11
-
-
Zhang, H.1
Luo, X.Q.2
Zhang, P.3
Huang, L.B.4
Zheng, Y.S.5
Wu, J.6
Zhou, H.7
Qu, L.H.8
Xu, L.9
Chen, Y.Q.10
-
12
-
-
59149098054
-
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
-
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y and Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009; 69(3):1135-1142.
-
(2009)
Cancer Res.
, vol.69
, Issue.3
, pp. 1135-1142
-
-
Su, H.1
Yang, J.R.2
Xu, T.3
Huang, J.4
Xu, L.5
Yuan, Y.6
Zhuang, S.M.7
-
13
-
-
84867742828
-
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
-
Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A and Giordano S. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene. 2012; 31(42):4517-4526.
-
(2012)
Oncogene.
, vol.31
, Issue.42
, pp. 4517-4526
-
-
Petrelli, A.1
Perra, A.2
Schernhuber, K.3
Cargnelutti, M.4
Salvi, A.5
Migliore, C.6
Ghiso, E.7
Benetti, A.8
Barlati, S.9
Ledda-Columbano, G.M.10
Portolani, N.11
De Petro, G.12
Columbano, A.13
Giordano, S.14
-
14
-
-
84880305345
-
miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling
-
Gebeshuber CA and Martinez J. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene. 2013; 32(27):3306-3310.
-
(2013)
Oncogene.
, vol.32
, Issue.27
, pp. 3306-3310
-
-
Gebeshuber, C.A.1
Martinez, J.2
-
15
-
-
84874098541
-
miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR
-
Xu C, Zeng Q, Xu W, Jiao L, Chen Y, Zhang Z, Wu C, Jin T, Pan A, Wei R, Yang B and Sun Y. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol Cancer Ther. 2013; 12(2):207-219.
-
(2013)
Mol Cancer Ther.
, vol.12
, Issue.2
, pp. 207-219
-
-
Xu, C.1
Zeng, Q.2
Xu, W.3
Jiao, L.4
Chen, Y.5
Zhang, Z.6
Wu, C.7
Jin, T.8
Pan, A.9
Wei, R.10
Yang, B.11
Sun, Y.12
-
16
-
-
84868675551
-
MicroRNA-100 is a potential molecular marker of nonsmall cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
-
Liu J, Lu KH, Liu ZL, Sun M, De W and Wang ZX. MicroRNA-100 is a potential molecular marker of nonsmall cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer. 2012; 12:519.
-
(2012)
BMC Cancer.
, vol.12
, pp. 519
-
-
Liu, J.1
Lu, K.H.2
Liu, Z.L.3
Sun, M.4
De, W.5
Wang, Z.X.6
-
17
-
-
84885909874
-
MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
-
Li XJ, Luo XQ, Han BW, Duan FT, Wei PP and Chen YQ. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. Br J Cancer. 2013; 109(8):2189-2198.
-
(2013)
Br J Cancer.
, vol.109
, Issue.8
, pp. 2189-2198
-
-
Li, X.J.1
Luo, X.Q.2
Han, B.W.3
Duan, F.T.4
Wei, P.P.5
Chen, Y.Q.6
-
18
-
-
84855349331
-
MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia
-
Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, Zeng CW, Lin KY, Zhou H, Qu LH, Zhang P and Chen YQ. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene. 2012; 31(1):80-92.
-
(2012)
Oncogene.
, vol.31
, Issue.1
, pp. 80-92
-
-
Zheng, Y.S.1
Zhang, H.2
Zhang, X.J.3
Feng, D.D.4
Luo, X.Q.5
Zeng, C.W.6
Lin, K.Y.7
Zhou, H.8
Qu, L.H.9
Zhang, P.10
Chen, Y.Q.11
-
19
-
-
75749122303
-
Methods in mammalian autophagy research
-
Mizushima N, Yoshimori T and Levine B. Methods in mammalian autophagy research. Cell. 2010; 140(3):313-326.
-
(2010)
Cell.
, vol.140
, Issue.3
, pp. 313-326
-
-
Mizushima, N.1
Yoshimori, T.2
Levine, B.3
-
20
-
-
47249094223
-
Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells
-
Scarlatti F, Maffei R, Beau I, Codogno P and Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 2008; 15(8):1318-1329.
-
(2008)
Cell Death Differ.
, vol.15
, Issue.8
, pp. 1318-1329
-
-
Scarlatti, F.1
Maffei, R.2
Beau, I.3
Codogno, P.4
Ghidoni, R.5
-
21
-
-
78149475088
-
Regulation of mammalian autophagy in physiology and pathophysiology
-
Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010; 90(4):1383-1435.
-
(2010)
Physiol Rev.
, vol.90
, Issue.4
, pp. 1383-1435
-
-
Ravikumar, B.1
Sarkar, S.2
Davies, J.E.3
Futter, M.4
Garcia-Arencibia, M.5
Green-Thompson, Z.W.6
Jimenez-Sanchez, M.7
Korolchuk, V.I.8
Lichtenberg, M.9
Luo, S.10
Massey, D.C.11
Menzies, F.M.12
Moreau, K.13
Narayanan, U.14
Renna, M.15
Siddiqi, F.H.16
-
22
-
-
77953168294
-
Regulation of insulin-like growth factormammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors
-
Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP and Lalli E. Regulation of insulin-like growth factormammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res. 2010; 70(11):4666-4675.
-
(2010)
Cancer Res.
, vol.70
, Issue.11
, pp. 4666-4675
-
-
Doghman, M.1
El Wakil, A.2
Cardinaud, B.3
Thomas, E.4
Wang, J.5
Zhao, W.6
Peralta-Del Valle, M.H.7
Figueiredo, B.C.8
Zambetti, G.P.9
Lalli, E.10
-
23
-
-
77951227871
-
TOR-dependent control of autophagy: biting the hand that feeds
-
Neufeld TP. TOR-dependent control of autophagy: biting the hand that feeds. Curr Opin Cell Biol. 2010; 22(2):157-168.
-
(2010)
Curr Opin Cell Biol.
, vol.22
, Issue.2
, pp. 157-168
-
-
Neufeld, T.P.1
-
24
-
-
0344142468
-
Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21
-
Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC and Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999; 59(1):59-65.
-
(1999)
Genomics.
, vol.59
, Issue.1
, pp. 59-65
-
-
Aita, V.M.1
Liang, X.H.2
Murty, V.V.3
Pincus, D.L.4
Yu, W.5
Cayanis, E.6
Kalachikov, S.7
Gilliam, T.C.8
Levine, B.9
-
25
-
-
64549101639
-
Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability
-
Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, Ahn CH, Yoo NJ and Lee SH. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009; 217(5):702-706.
-
(2009)
J Pathol.
, vol.217
, Issue.5
, pp. 702-706
-
-
Kang, M.R.1
Kim, M.S.2
Oh, J.E.3
Kim, Y.R.4
Song, S.Y.5
Kim, S.S.6
Ahn, C.H.7
Yoo, N.J.8
Lee, S.H.9
-
26
-
-
45049083880
-
Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability
-
Kim MS, Jeong EG, Ahn CH, Kim SS, Lee SH and Yoo NJ. Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol. 2008; 39(7):1059-1063.
-
(2008)
Hum Pathol.
, vol.39
, Issue.7
, pp. 1059-1063
-
-
Kim, M.S.1
Jeong, E.G.2
Ahn, C.H.3
Kim, S.S.4
Lee, S.H.5
Yoo, N.J.6
-
27
-
-
50149095124
-
Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome
-
Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, Kinoshita T, Ueno T, Esumi H and Ochiai A. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 2008; 99(9):1813-1819.
-
(2008)
Cancer Sci.
, vol.99
, Issue.9
, pp. 1813-1819
-
-
Fujii, S.1
Mitsunaga, S.2
Yamazaki, M.3
Hasebe, T.4
Ishii, G.5
Kojima, M.6
Kinoshita, T.7
Ueno, T.8
Esumi, H.9
Ochiai, A.10
-
28
-
-
33847754341
-
Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model
-
Chang CP, Yang MC, Liu HS, Lin YS and Lei HY. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology. 2007; 45(2):286-296.
-
(2007)
Hepatology.
, vol.45
, Issue.2
, pp. 286-296
-
-
Chang, C.P.1
Yang, M.C.2
Liu, H.S.3
Lin, Y.S.4
Lei, H.Y.5
-
29
-
-
56449127196
-
OSU-03012, a novel celecoxib derivative, induces reactive oxygen speciesrelated autophagy in hepatocellular carcinoma
-
Gao M, Yeh PY, Lu YS, Hsu CH, Chen KF, Lee WC, Feng WC, Chen CS, Kuo ML and Cheng AL. OSU-03012, a novel celecoxib derivative, induces reactive oxygen speciesrelated autophagy in hepatocellular carcinoma. Cancer Res. 2008; 68(22):9348-9357.
-
(2008)
Cancer Res.
, vol.68
, Issue.22
, pp. 9348-9357
-
-
Gao, M.1
Yeh, P.Y.2
Lu, Y.S.3
Hsu, C.H.4
Chen, K.F.5
Lee, W.C.6
Feng, W.C.7
Chen, C.S.8
Kuo, M.L.9
Cheng, A.L.10
-
30
-
-
73449102143
-
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells
-
Song J, Qu Z, Guo X, Zhao Q, Zhao X, Gao L, Sun K, Shen F, Wu M and Wei L. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy. 2009; 5(8):1131-1144.
-
(2009)
Autophagy.
, vol.5
, Issue.8
, pp. 1131-1144
-
-
Song, J.1
Qu, Z.2
Guo, X.3
Zhao, Q.4
Zhao, X.5
Gao, L.6
Sun, K.7
Shen, F.8
Wu, M.9
Wei, L.10
-
31
-
-
84893863060
-
mTOR pathway in colorectal cancer: an update
-
Francipane MG and Lagasse E. mTOR pathway in colorectal cancer: an update. Oncotarget. 2014; 5(1):49-66.
-
(2014)
Oncotarget.
, vol.5
, Issue.1
, pp. 49-66
-
-
Francipane, M.G.1
Lagasse, E.2
-
32
-
-
54449083925
-
Molecular targeted therapies in hepatocellular carcinoma
-
Llovet JM and Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008; 48(4):1312-1327.
-
(2008)
Hepatology.
, vol.48
, Issue.4
, pp. 1312-1327
-
-
Llovet, J.M.1
Bruix, J.2
-
33
-
-
77953973648
-
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
-
Ulanet DB, Ludwig DL, Kahn CR and Hanahan D. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci U S A. 2010; 107(24):10791-10798.
-
(2010)
Proc Natl Acad Sci U S A.
, vol.107
, Issue.24
, pp. 10791-10798
-
-
Ulanet, D.B.1
Ludwig, D.L.2
Kahn, C.R.3
Hanahan, D.4
-
34
-
-
84870692721
-
Exploiting the mTOR paradox for disease prevention
-
Iglesias-Bartolome R and Gutkind SJ. Exploiting the mTOR paradox for disease prevention. Oncotarget. 2012; 3(10):1061-1063.
-
(2012)
Oncotarget.
, vol.3
, Issue.10
, pp. 1061-1063
-
-
Iglesias-Bartolome, R.1
Gutkind, S.J.2
-
35
-
-
77949875878
-
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
-
Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Sole M, Thung S, Moyano S, Toffanin S, Minguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J and Llovet JM. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol. 2010; 52(4):550-559.
-
(2010)
J Hepatol.
, vol.52
, Issue.4
, pp. 550-559
-
-
Tovar, V.1
Alsinet, C.2
Villanueva, A.3
Hoshida, Y.4
Chiang, D.Y.5
Sole, M.6
Thung, S.7
Moyano, S.8
Toffanin, S.9
Minguez, B.10
Cabellos, L.11
Peix, J.12
Schwartz, M.13
Mazzaferro, V.14
Bruix, J.15
Llovet, J.M.16
-
37
-
-
64349104998
-
mTOR inhibitors for hepatocellular cancer: a forward-moving target
-
Treiber G. mTOR inhibitors for hepatocellular cancer: a forward-moving target. Expert Rev Anticancer Ther. 2009; 9(2):247-261.
-
(2009)
Expert Rev Anticancer Ther.
, vol.9
, Issue.2
, pp. 247-261
-
-
Treiber, G.1
-
38
-
-
32944457518
-
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, Baselga J and Rosen N. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006; 66(3):1500-1508.
-
(2006)
Cancer Res.
, vol.66
, Issue.3
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
Solit, D.4
Mills, G.B.5
Smith, D.6
Lane, H.7
Hofmann, F.8
Hicklin, D.J.9
Ludwig, D.L.10
Baselga, J.11
Rosen, N.12
-
39
-
-
79951816312
-
Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors
-
Quek R, Wang Q, Morgan JA, Shapiro GI, Butrynski JE, Ramaiya N, Huftalen T, Jederlinic N, Manola J, Wagner AJ, Demetri GD and George S. Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res. 2011; 17(4):871-879.
-
(2011)
Clin Cancer Res.
, vol.17
, Issue.4
, pp. 871-879
-
-
Quek, R.1
Wang, Q.2
Morgan, J.A.3
Shapiro, G.I.4
Butrynski, J.E.5
Ramaiya, N.6
Huftalen, T.7
Jederlinic, N.8
Manola, J.9
Wagner, A.J.10
Demetri, G.D.11
George, S.12
-
40
-
-
77950602604
-
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma
-
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH and Zhuang SM. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2009; 51(3):836-845.
-
(2009)
Hepatology.
, vol.51
, Issue.3
, pp. 836-845
-
-
Xiong, Y.1
Fang, J.H.2
Yun, J.P.3
Yang, J.4
Zhang, Y.5
Jia, W.H.6
Zhuang, S.M.7
|